U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363044) titled 'A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease' on Jan. 15.
Brief Summary: This is a multicentre, prospective, randomised, controlled, open-label study to assess the efficacy, safety, and cost-effectiveness of epigenome-guided treatment selection compared to usual standard-of-care (SOC) treatment selection in patients initiating biologic therapy for the treatment of their active Crohn's Disease (CD).
Study Start Date: Feb. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Crohn Disease (CD)
Intervention:
DEVICE: Epigenome...